LadRx (LADX) Stock Price, Quote, News & History

Comments

LadRx Corp (LADX) Stock Price, Quote, News & History

LADXOTCEM

Trade with Public

$0.0510

At close: Mar 27, 5:00 PM EST

OverviewNews Short Interest

Key Statistics

Open

Volume / Avg.

64.00 / 1.10K

Day Range

- - -

52 Wk Range

0.00 - 2.20

Market Cap

$25.25K

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent LadRx Corp News

Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019

FDA approves Alcon's Tryptyr for dry eye disease, backed by Phase 3 trials showing strong efficacy in increasing natural tear production.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-1.86M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

Free Cash Flow (TTM)

-1.86M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-1.86M

Valuation Metrics

Enterprise Value

-$2.01M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

-9882.35%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$4.31

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$206.95K

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

64.00 / 1.10K

Day Range

- - -

52 Wk Range

0.00 - 2.20

Market Cap

$25.25K

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

LadRx Corp operates as a biopharmaceutical research and development company in the healthcare sector of the United States. It is focused on the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linke...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy LadRx (LADX) stock?

You can purchase shares of LadRx (OTCEM:LADX) through any online brokerage.

View our list of the best stock brokerages

Who are LadRx (LADX) competitors?

There are no as such competitors for LadRx.

What is the forecast, or price target, for LadRx (LADX) stock?

There is no analysis for LadRx to provide a consensus price target.

What is the current price for LadRx (LADX)?

The stock price for LadRx (OTCEM: LADX) is $0.051 last updated March 12, 2026 at 3:52 PM EDT.

Does LadRx (LADX) pay a dividend?

There are no upcoming dividends for LadRx.

When is LadRx (OTCEM:LADX) reporting earnings?

LadRx does not have any upcoming earnings scheduled.

Is LadRx (LADX) going to split?

There is no upcoming split for LadRx.

What sector and industry does LadRx (LADX) operate in?

LadRx is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.

Key Statistics

Open

Volume / Avg.

64.00 / 1.10K

Day Range

- - -

52 Wk Range

0.00 - 2.20

Market Cap

$25.25K

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent LadRx Corp News

Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019

FDA approves Alcon's Tryptyr for dry eye disease, backed by Phase 3 trials showing strong efficacy in increasing natural tear production.

Vandana Singh